Form D · Biotechnology

ImmVue Therapeutics Inc.

Toronto, A6 · CIK 0002009514

Offering snapshot reported Apr 18, 2024 · SEC filing

Reported sold
$529K
Offering amount: $529K
Investors reported
3
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Jan 31, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$265K$529KMar 19, 2024: $154,050.00Mar 19, 2024Apr 18, 2024: $529,300.00Apr 18, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$154,050 → $529,300
  • Reported investors2 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 18, 2024Amendment$529,300$375,250vs Mar 19, 20243SEC filing
Mar 19, 2024Initial$154,050No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-508035

Source: Form D, filed Apr 18, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sandy Der Director, Executive
Joon Hyung John Kim Director
David Moon Director, Executive
Jayan Nagendran Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
252 Russell Hill Rd
Toronto, A6, M4V 2T2